June 28, 2019 | City of Hope
At ASCO, City of Hope presented on a number of topics, but some of the most noteworthy involved the first KRAS inhibitor to show anti-tumor activity and the use of CAR T cell therapy in chronic lymphocytic leukemia.
New hormone and immunotherapy trial for breast cancer patients
October 8, 2018 | City of Hope
This phase 2 trial studies the side effects and how well pembrolizumab and enobosarm work in treating patients with androgen receptor positive triple-negative breast cancer that has spread to other places in the body.
City of Hope Awarded $3.7 million to Develop Glioblastoma Clinical Trial
June 29, 2018 | Letisia Marquez
California Institute for Regenerative Medicine has awarded City of Hope $3.7 million to develop a phase 1 clinical trial for glioblastoma patients, which would genetically alter blood stem cells to better tolerate chemotherapy.
Researchers Use Nanoparticles to Test Treatment for Liver Disease
June 25, 2018 | Katie Neith
In an effort to improve options for those with liver cancer, a group of researchers have identified a way of potentially treating a broad range of liver diseases and perhaps even other types of cancer.
Jianjun Chen, Ph.D., Takes Aim at Acute Myeloid Leukemia
May 15, 2018 | City of Hope
Jianjun Chen, Ph.D., a new faculty member at City of Hope, dedicates much of his research program to learning more about acute myeloid leukemia (AML), one of the most common and deadly forms of blood cancer.
Farah R. Abdulla, M.D., Joins Lymphoma Research Team
January 25, 2018 | City of Hope
Farah Abdulla, M.D., specializes in the research and treatment of cutaneous lymphoma, a rare form of non-Hodgkin lymphoma that affects the skin.
Get Access Now: Car t Cell Therapy for Aggressive Non-Hodgkin Lymphoma
November 17, 2017 | City of Hope
City of Hope is now offering the first-ever FDA-approved CAR T cell therapy for adult patients with certain types of large B-cell lymphoma who have not responded to or who have relapsed after at least two other kinds of treatment.